Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

Similar articles for PubMed (Select 17540599)


Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.

Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, Arking DE, Beer MA, Maitra A, Mendell JT.

Mol Cell. 2007 Jun 8;26(5):745-52. Epub 2007 May 31.


Micro(mi) RNA-34a targets protein phosphatase (PP)1γ to regulate DNA damage tolerance.

Takeda Y, Venkitaraman AR.

Cell Cycle. 2015 Jun 25:0. [Epub ahead of print]


p53-dependent non-coding RNA networks in Chronic Lymphocytic Leukemia.

Blume CJ, Hotz-Wagenblatt A, Hüllein J, Sellner L, Jethwa A, Stolz T, Slabicki M, Lee K, Sharathchandra A, Benner A, Dietrich S, Oakes CC, Dreger P, Te Raa D, Kater AP, Jauch A, Merkel O, Oren M, Hielscher T, Zenz T.

Leukemia. 2015 May 14. doi: 10.1038/leu.2015.119. [Epub ahead of print]


MiR-34a promotes Fas-mediated cartilage endplate chondrocyte apoptosis by targeting Bcl-2.

Chen H, Wang J, Hu B, Wu X, Chen Y, Li R, Yuan W.

Mol Cell Biochem. 2015 Apr 25. [Epub ahead of print]


The p53/miR-34a/SIRT1 Positive Feedback Loop in Quercetin-Induced Apoptosis.

Lou G, Liu Y, Wu S, Xue J, Yang F, Fu H, Zheng M, Chen Z.

Cell Physiol Biochem. 2015;35(6):2192-202. doi: 10.1159/000374024. Epub 2015 Apr 7.


Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma.

Rihani A, Van Goethem A, Ongenaert M, De Brouwer S, Volders PJ, Agarwal S, De Preter K, Mestdagh P, Shohet J, Speleman F, Vandesompele J, Van Maerken T.

Sci Rep. 2015 Mar 12;5:9027. doi: 10.1038/srep09027.


Low miR-34a and miR-192 are associated with unfavorable prognosis in patients suffering from osteosarcoma.

Wang Y, Jia LS, Yuan W, Wu Z, Wang HB, Xu T, Sun JC, Cheng KF, Shi JG.

Am J Transl Res. 2015 Jan 15;7(1):111-9. eCollection 2015.


miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression.

Mu W, Hu C, Zhang H, Qu Z, Cen J, Qiu Z, Li C, Ren H, Li Y, He X, Shi X, Hui L.

Cell Res. 2015 Apr;25(4):477-95. doi: 10.1038/cr.2015.23. Epub 2015 Feb 20.


Growth differentiation factor-15 encodes a novel microRNA 3189 that functions as a potent regulator of cell death.

Jones MF, Ling Li X, Subramanian M, Shabalina SA, Hara T, Zhu Y, Huang J, Yang Y, Wakefield LM, Prasanth KV, Lal A.

Cell Death Differ. 2015 Feb 20. doi: 10.1038/cdd.2015.9. [Epub ahead of print]


miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy.

Bhattacharya A, Schmitz U, Raatz Y, Schönherr M, Kottek T, Schauer M, Franz S, Saalbach A, Anderegg U, Wolkenhauer O, Schadendorf D, Simon JC, Magin T, Vera J, Kunz M.

Oncotarget. 2015 Feb 20;6(5):2966-80.


Regulatory mechanisms and clinical perspectives of miR-34a in cancer.

Li L.

J Cancer Res Ther. 2014 Oct-Dec;10(4):805-10. doi: 10.4103/0973-1482.146084.


Anti-proliferative effects of polyphenols from pomegranate rind (Punica granatum L.) on EJ bladder cancer cells via regulation of p53/miR-34a axis.

Zhou B, Yi H, Tan J, Wu Y, Liu G, Qiu Z.

Phytother Res. 2015 Mar;29(3):415-22. doi: 10.1002/ptr.5267. Epub 2015 Jan 8.


p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.

Novello C, Pazzaglia L, Conti A, Quattrini I, Pollino S, Perego P, Picci P, Benassi MS.

PLoS One. 2014 Dec 9;9(12):e114757. doi: 10.1371/journal.pone.0114757. eCollection 2014.


Age-dependent increase in miRNA-34a expression in the posterior pole of the mouse eye.

Smit-McBride Z, Forward KI, Nguyen AT, Bordbari MH, Oltjen SL, Hjelmeland LM.

Mol Vis. 2014 Nov 5;20:1569-78. eCollection 2014.


p53 shapes genome-wide and cell type-specific changes in microRNA expression during the human DNA damage response.

Hattori H, Janky R, Nietfeld W, Aerts S, Madan Babu M, Venkitaraman AR.

Cell Cycle. 2014;13(16):2572-86. doi: 10.4161/15384101.2015.942209.


Genetic networks lead and follow tumor development: microRNA regulation of cell cycle and apoptosis in the p53 pathways.

Otsuka K, Ochiya T.

Biomed Res Int. 2014;2014:749724. doi: 10.1155/2014/749724. Epub 2014 Sep 11. Review.


Mir-34a mimics are potential therapeutic agents for p53-mutated and chemo-resistant brain tumour cells.

Fan YN, Meley D, Pizer B, Sée V.

PLoS One. 2014 Sep 24;9(9):e108514. doi: 10.1371/journal.pone.0108514. eCollection 2014.


Mir-34: a new weapon against cancer?

Misso G, Di Martino MT, De Rosa G, Farooqi AA, Lombardi A, Campani V, Zarone MR, Gullà A, Tagliaferri P, Tassone P, Caraglia M.

Mol Ther Nucleic Acids. 2014 Sep 23;3:e194. doi: 10.1038/mtna.2014.47. Review.


Hypofractionated radiotherapy induces miR-34a expression and enhances apoptosis in human nasopharyngeal carcinoma cells.

Long Z, Wang B, Tao D, Huang Y, Tao Z.

Int J Mol Med. 2014 Nov;34(5):1388-94. doi: 10.3892/ijmm.2014.1937. Epub 2014 Sep 17.


Expression of senescence-associated microRNAs and target genes in cellular aging and modulation by tocotrienol-rich fraction.

Khee SG, Yusof YA, Makpol S.

Oxid Med Cell Longev. 2014;2014:725929. doi: 10.1155/2014/725929. Epub 2014 Jul 14.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk